Ixekizumab reduces IL-17 and IL-23 pathway genes more rapidly than guselkumab: 4-week results from IXORA-R-MedSci.cn

Ixekizumab reduces IL-17 and IL-23 pathway genes more rapidly than guselkumab: 4-week results from IXORA-R

Garcet, S; Tsoi, LC; Blauvelt, A; Papp, KA; Krishnan, V; Konicek, B; Dow, ER; Gemperline, D; Elmaraghy, H; Krueger, J; Gudjonsson, JE

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023; 89 (3): AB59

科室
- - 订阅+
  - 更多科室
工具
服务